Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy

Figure 3

Comparison of outcomes of IVC, IVR, and IVTA groups at 6 m. There were no significant differences in operation time, incidence of iatrogenic retinal breaks, endodiathermy rate, and silicone oil tamponade between IVC and IVR groups. However, each of these two groups showed significant difference with the IVTA group.